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Abstract. A highly enantioselective Strecker reaction with 
dibenzo[b,f][1,4]oxazepines has been described using a 
dihydroquinine-derived thiourea as organocatalyst. The 
reaction affords chiral 10,11-
dihydrodibenzo[b,f][1,4]oxazepine 11-carbonitrile 
derivatives in excellent yields (up to 99%) and excellent 
enantioselectivities (up to 98%) under mild reaction 
conditions. 
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The asymmetric Strecker reaction is one of the most 
useful and important reactions for carbon-carbon bond 
formation,[1] providing enantioenriched α-amino 
nitriles.[2] This kind of compounds are very useful 
building blocks in organic synthesis, because they are 
precursors for value-added products such as α-amino 
acids and derivatives,[3] 1,2-diamines,[4]  or nitrogen 
heterocycles.[5] Despite the great achievements and the 
impressive progress in the enantioselective Strecker 
reactions, the main examples are focused on acyclic 
imines,[6] while the catalytic asymmetric Strecker 
reactions with cyclic imines are barely studied. The 
major efforts have been focus in the use of six 
membered cyclic imines.[7,8] Several groups have used 
3,4-dihydroisoquinoline as electrophile with different 
cyanide sources (Scheme 1a).[7] Ma and coworkers, in 
2012, described the organocatalytic Strecker reaction 
of trifluoromethyl-substituted cyclic ketimines with 
TMSCN.[8] While Tian reported the reaction with five 
membered and six membered cyclic imines using ethyl 
cyanoformate (Scheme 1b).[9] However, to the best of 
our knowledge, the catalytic asymmetric Strecker 
reaction of seven membered cyclic imines has not been 
reported to date. 
On the other hand, dibenzo[b,f][1,4]oxazepines are a 
class of nitrogen heterocycle that recently have 
received great attention from the pharmaceutical 
industry due to the widespread biological activities 
presented in dibenzo[b,f][1,4]oxazepine 
derivatives.[10] In this context, 11-substituted 10,11-
dihydrodibenzo[b,f][1,4]oxazepine derivatives play an 
important role in medicinal chemistry, and several 
examples of catalytic asymmetric methodologies 
using dibenzo[b,f][1,4]oxazepine derivatives as 
electrophiles have been described in the literature.[11, 
12] However, the enantioselective Strecker reaction 
with these seven membered cyclic imines have not 
been described. Herein we present an organocatalytic 
enantioselective Strecker reaction of seven membered 
cyclic imines catalyzed by a Cinchona alkaloid-based 
thiourea.[13] 
a) Enantioselective Strecker reaction with six membered cyclic imines (ref. 7)
b) Enantioselective Strecker reaction with five membered cyclic imines (ref. 9)
c) Enantioselective Strecker reaction with seven membered cyclic imines (This work )
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Scheme 1. Enantioselective Strecker reaction with cyclic 
imines. 
Based on our experience in bifunctional catalysis,[14] 
we began our investigations by studying the reaction 
of dibenzo[b,f][1,4]oxazepine 1a with TMSCN 2a 
with various bifunctional organocatalysts in toluene at 
room temperature (Scheme 2).  Quinine (I) could not 
catalyzed efficiently the reaction and the product 3a 
was obtained with only 5% yield, after 7 days, with 6% 
ee. Cupreine derivative II showed higher catalytic 
activity, leading to product 3a with a 93% yield after 7 
 2
days, but the product was obtained as a racemic 
mixture. Next, we tried the reaction using thiourea-
based organocatalyst. So, in the presence of quinine-
derived thiourea III, used by Zhou on asymmetric 
Strecker reactions with acyclic imines,[15] the reaction 
proceed with higher enantioselectivity, obtaining the 
product 3a with a promising 79% ee. However, 
cinchonidine-derived thiourea IV, was less efficient 
and a decreasing on the enantiomeric excess was 
observed. Commercial thioureas, such as the catalysts 
of Jacobsen[16] (V) and Takemoto[17] (VI) showed good 
catalytic activity, but in both cases the reaction 
proceeded with lower enantioselectivity (62% and 
73 % ee, respectively). We also tried squaramide-
based organocatalysts, such as squaramides VII and 
VIII, which showed lower catalytic activity and 
enantioselectivity. Consequently, we returned to the 
use of thiourea-based organocatalyst. Quinidine-
derived thiourea IX gave similar yield (66%) than 
quinine-based thiourea III, but lower ee (70%). 
Therefore, the best skeleton of Cinchona alkaloids to 
obtain the higher enantioselectivity is the one present 
in quinine. Finally, the thiourea X, prepared from 
dihydroquinine, displayed the highest enantiomeric 
excess and product 3a was obtained with 84% yield 
and 89% ee after 2 days. 
 
 
Scheme 2. Optimization of the catalyst in the 
enantioselective Strecker reaction. Reaction conditions: 0.1 
mmol 1a, 0.225 mmol 2a, and catalyst (5 mol%) in toluene 
(1 mL) at rt. a) Opposite enantiomer was obtained. 
Therefore, we chose catalyst X to continue the 
optimization of the reaction conditions, including the 
change of cyanide source, solvent, temperatures and 
additives (Table 1). First, we tried Strecker reaction 
with other cyanide sources (entries 1-3, Table 1). Ethyl 
cyanoformate 2b, was less efficient in this reaction 
obtaining the α-amino nitrile 3a with lower yield and 
enantiomeric excess (entry 2) than TMSCN (entry 1), 
while with KCN the product 3a was not formed. Other 
solvents were also screened (entries 4-12), being 
toluene (entry 1), dichloromethane (entry 8) and 
dichloroethane (entry 10) the best solvents. We chose 
DCE to continue the optimization process, because the 
enantioselectivity of the reaction was slightly higher. 
By lowering the reaction temperature to 4 ºC (entry 13), 
the enantioselectivity increased to an excellent 95% ee, 
however the reactivity was much lower and we need 6 
days to achieve full conversion. The Strecker product 
3a could be also achieved with good enantiomeric 
excess when 2 mol% of catalyst X was used (entry 14). 
Finally, we evaluated the addition of alcohols as 
additives. The addition of 1 equivalent of 
trifluoroethanol[18] (entry 15) increase the reactivity, 
and full conversion was achieved in only 30 hours, 
while the enantioselectivity was still excellent (95% 
ee). Ethanol was also evaluated as additive (entry 16), 
with similar results than trifluoroethanol. 
Table 1. Optimization of the reaction conditions.a 
 
Entry Solvent T 
(ºC) 
t (h) Y. 
(%)b 
ee 
(%)c 
1 toluene rt 48 84 89 
2d toluene rt 48 77 61 
3e toluene rt 72 - - 
4 p-xylene rt 48 98 85 
5 Et2O rt 72 96 85 
6 MTBE rt 96 64 55 
7 THF rt 72 30 9 
8 CH2Cl2 rt 72 89 90 
9 CHCl3 rt 24 99 76 
10 DCE rt 48 85 91 
11 AcOEt rt 168 24 62 
12 MeOH rt 72 98 0 
13 DCE 4 144 87 95 
14f DCE 4 144 82 93 
15g DCE 4 30 93 95 
16h DCE 4 30 92 94 
a) Reaction conditions: 0.1 mmol 1a, 0.225 mmol 2a, and X 
(5 mol%) in solvent (1 mL) at rt. b) Isolated yield after 
column chromatography. c) Enantiomeric excess determined 
by chiral HPLC. d) NCCO2Et (2b) was used instead of 2a. e) 
KCN (2c) was used instead of 2a. f) 2 mol% of X was used. 
g) CF3CH2OH (0.1 mmol) was used as additive. h) 
CH3CH2OH (0.1 mmol) was used as additive. 
With the optimized reaction conditions in hand (entry 
16, Table 1), we proceeded to study the scope of the 
Strecker reaction of dibenzo[b,f][1,4]oxazepines 1 
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with TMSCN 2a (Scheme 3). A wide range of 
substituted cyclic imines 1, with both electron-
donating (MeO, Me, tBu) and electron-withdrawing 
(Cl, F, Br) substituents at different positions of the two 
aromatic rings, afforded the corresponding chiral β-
amino nitriles 3a–3p with high yields (up to 99%) and 
enantioselectivities (up to 98% ee). For the cyclic 
imine 1l, bearing two methoxy groups in the aromatic 
ring, a lower enantioselectivity was observed (86% ee) 
probably due to the presence of the methoxy group 
next to the C=N electrophilic double bond. While with 
dibenzoxazepine 1m bearing 3 substituents an 
excellent 98% ee was obtained. Cyclic seven 
membered imines bearing a naphthyl ring (1n–1p), 
were also suitable for the Strecker reaction, affording 
the corresponding α-amino nitriles with good yields 
and high enantiomeric excesses. 
  
Scheme 3. Scope of the Strecker reaction of 
dibenzoxazepines with TMSCN. Reaction conditions: 1 (0.1 
mmol), 2a (0.225 mmol), TFE (0.1 mmol) and catalyst X (5 
mol%) in DCE (1 mL) at 4ºC for 48-96 h.a) 1 mmol reaction 
scale. 
We further studied the Strecker reaction of 
dibenzo[b,f][1,4]thiazepine 4a with TMSCN (Scheme 
4). When the cyclic imine 4a was used as a substrate, 
the corresponding α-amino nitrile 6a was obtained 
with excellent yield (99%) and high enantiomeric 
excess (93% ee). Moreover, we have tested the 
reaction with 11H-dibenzo[b,e]azepine 
(morphanthridine, 5a), obtaining the corresponding 
product 7a, with excellent yield (98%), however with 
moderate enantioselectivity (50% ee). This result 
shows the importance of the presence of a heteroatom 
in the seven-membered cyclic imine to obtain high 
enantioselectivity in the organocatalytic Strecker 
reaction.  
  
Scheme 4. Asymmetric Strecker reaction with 
dibenzo[b,f][1,4]thiazepine 4a and 11H-
dibenzo[b,e]azepine 5a. 
After having proved the efficiency of our methodology 
for the enantioselective Strecker reaction with seven 
membered cyclic aldimines, we turned our attention to 
cyclic ketimines. Unfortunately, when 11-
methyldibenzo[b,f][1,4]oxazepine 8a was tested under 
the optimized reaction conditions the α-amino nitrile 
9a was obtained with low yield (39%) and low 
enantioselectivity (27% ee) after 7 days at rt, probably 
due to steric problems. 
 
Scheme 5. Asymmetric Strecker reaction with seven 
membered cyclic ketimine 8a. 
The absolute configuration of the stereogenic centre in 
compound 3i was determined to be (R) on the basis of 
X-ray crystallographic analysis (Scheme 6); the 
configuration of the rest of the products 3 were 
assigned on the assumption of a uniform mechanistic 
pathway.[19] A plausible transition-state model is 
depicted in Scheme 6. The thiourea catalyst is the 
responsible for the preorientation and the activation of 
the substrates acting as bifunctional organocatalyst. It 
is reasonable that TMSCN in the presence of an 
alcohol (ROH), generates HCN and TMSOR, during 
the enantioselective Strecker reaction. Therefore, an 
ammonium salt derived from the dihydroquinine-
derived thiourea and HCN can be formed. The cyanide 
anion can be activated by the thiourea moiety of the 
catalyst, while the dibenzo[b,f][1,4]oxazepine is 
activated upon formation of a hydrogen bond with the 
ammonium salt.[9] The cyanide will be directed to the 
Si-face of the imine, thus accounting for the observed 
enantioselectivity. 
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Scheme 6. Plausible transition-state model and X-ray 
crystal structure of 3i. 
In summary, we have developed an organocatalytic 
enantioselective Strecker reaction of TMSCN with 
dibenzo[b,f][1,4]oxazepines, using a dihydroquinine-
derived thiourea organocatalyst, obtaining the 
corresponding chiral α-amino nitriles with excellent 
yields (up to 99%) and enantioselectivities (up to 98% 
ee). We think that this procedure provides a successful 
approach for the synthesis of chiral 10,11-
dihydrodibenzo[b,f][1,4]oxazepine 11-carbonitrile 
derivatives and expand the repertoire of asymmetric 
Strecker reactions in organic synthesis. 
Experimental Section 
General procedure for the enantioselective Strecker 
reaction  
To a solution of the cyclic imine 1a (19.5 mg, 0.1 mmol) 
and chiral organocatalyst X (2.98 mg, 0.005 mmol) in 
dichloroethane (1 mL), 2a (28 µL, 0.225 mmol) and 2,2,2-
trifluoroethanol (7 µL, 0.1 mmol) were added. The mixture 
was cooled to 4ºC and stirred at this temperature until TLC 
analysis indicated full conversion of the starting material. 
Finally, the reaction mixture was directly poured into a 
column chromatography, using hexane:Et2O mixtures (8:2 
to 7:3) as eluent to afford the product 3aa (20.6 mg, 0.093 
mmol). 
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